cannabis indica

Câncer — Leucemia

termo de indexação original: Cancer - Leukemia

O acervo do Cannabis Indica reúne 41 estudos científicos que tocam a condição Câncer — Leucemia, publicados entre 1975 e 2022. Pela leitura automatizada, 31 (76%) foram classificados como favoráveis, 4 (10%) como inconclusivos e 6 (15%) como desfavoráveis — uma leitura de máquina, feita para navegar, não para concluir. O desenho mais frequente é estudo laboratorial (24 estudos), seguido de metanálise (16). Os compostos mais presentes são Tetraidrocanabinol (THC), Endocanabinoide (não especificado) e Canabinoides Sintéticos AM-x. Aparece com frequência ao lado de Câncer, Câncer — Mama e Câncer — Cérebro.

Estudos indexados
41
Período coberto
1975–2022
Favoráveis
31 · 76%
Inconclusivos
4 · 10%
Desfavoráveis
6 · 15%
Termo original
Cancer - Leukemia

O acervo em números

Tipo de estudo

Estudo Laboratorial24
Metanálise16
Ensaio Clínico1

Direção do resultado

Favorável31
Inconclusivo4
Desfavorável6

Por década

1970s1
2000s8
2010s14
2020s18

41 estudos

Filtrar e buscar no acervo →
  1. 2022

    Biological effects of cannabidiol on human cancer cells: Systematic review of the literature

  2. 2022

    Cannabinoids as anticancer drugs: current status of preclinical research

  3. 2022

    Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia

  4. 2022

    Controversial Link between Cannabis and Anticancer Treatments—Where Are We and Where Are We Going? A Systematic Review of the Literature

    FavorávelMetanáliseDorCâncerAnsiedadeTetraidrocanabinol (THC)THC Farmacêutico+17
  5. 2022

    Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study

    DesfavorávelMetanáliseCâncer — MamaCâncer — PulmãoCâncer — CólonDelta-8-THC+16
  6. 2022

    Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions

  7. 2022

    Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia

    FavorávelEstudo LaboratorialCâncer
  8. 2022

    The oncogenic lysophosphatidylinositol (LPI)/GPR55 signaling

  9. 2022

    The Role of Nutritional Status, Gastrointestinal Peptides, and Endocannabinoids in the Prognosis and Treatment of Children with Cancer

    InconclusivoMetanáliseDorCâncerObesidadeAnandamida (AEA)Tetraidrocanabinol (THC)+17
  10. 2021

    ACPA decreases non-small cell lung cancer line growth through Akt/PI3K and JNK pathways in vitro

  11. 2021

    Cannabidiol Enhances Intestinal Cannabinoid Receptor Type 2 Receptor Expression and Activation Increasing Regulatory T Cells and Reduces Murine Acute Graft-versus-Host Disease without Interfering with the Graft-versus-Leukemia Response

    FavorávelEstudo LaboratorialCâncerRejeição de TransplanteDoença do Enxerto contra Hospedeiro
  12. 2021

    Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study

  13. 2021

    Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development

  14. 2021

    Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies

  15. 2021

    Tamoxifen Sensitizes Acute Lymphoblastic Leukemia Cells to Cannabidiol by Targeting Cyclophilin-D and Altering Mitochondrial Ca2+ Homeostasis

    FavorávelEstudo LaboratorialCâncer
  16. 2021

    Tea tree oil extract causes mitochondrial superoxide production and apoptosis as an anticancer agent, promoting tumor infiltrating neutrophils cytotoxic for breast cancer to induce tumor regression

    FavorávelEstudo LaboratorialCâncerEstresse OxidativoCâncer — MamaOutros Compostos Relacionados+6
  17. 2021

    The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology

    InconclusivoMetanáliseCâncerCâncer — CérebroCâncer — Neuroblastoma+1
  18. 2020

    Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

  19. 2019

    Assessment of Cannabinoids Agonist and Antagonist in Invasion Potential of K562 Cancer Cells

  20. 2019

    Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia

    FavorávelEstudo LaboratorialCâncer
  21. 2018

    Anti-Proliferative Properties and Proapoptotic Function of New CB2 Selective Cannabinoid Receptor Agonist in Jurkat Leukemia Cells

    FavorávelEstudo LaboratorialCâncerCanabinoide Sintético (não especificado)
  22. 2017

    Anticancer Effects Of Phytocannabinoids Used With Chemotherapy In Leukaemia Cells Can Be Improved By Altering The Sequence Of Their Administration

    FavorávelEstudo LaboratorialCâncerTetraidrocanabinol (THC)Canabigerol (CBG)
  23. 2017

    Cannabidiol Reduces Leukemic Cell Size – But Is It Important?

    FavorávelEstudo LaboratorialCâncer
  24. 2016

    Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation

    InconclusivoEstudo LaboratorialCâncerAnandamida (AEA)Canabinoides Sintéticos AM-x+1
  25. 2016

    Dronabinol has preferential antileukemic activity in acute lymphoblastic and myeloid leukemia with lymphoid differentiation patterns.

    FavorávelEstudo LaboratorialCâncerTHC Farmacêutico
  26. 2016

    β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties.

    FavorávelMetanáliseDorCâncerInflamação+16
  27. 2015

    Cytotoxicity of Endogenous Lipids N-acyl Dopamines and Their Possible Metabolic Derivatives for Human Cancer Cell Lines of Different Histological Origin

  28. 2015

    Selected Compounds Structurally Related to Acyclic Sesquiterpenoids and Their Antibacterial and Cytotoxic Activity

    FavorávelEstudo LaboratorialCâncerInfecções BacterianasCâncer — Pulmão+2
  29. 2013

    Cannabis Extract Treatment for Terminal Acute Lymphoblastic Leukemia with a Philadelphia Chromosome Mutation

    FavorávelMetanáliseCâncer
  30. 2013

    Composition and in vitro anticancer activities of the leaf essential oil of Neolitsea variabillima from Taiwan.

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoCâncer — Cólon+3
  31. 2012

    Cannabidiol As Potential Anticancer Drug

  32. 2011

    Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-Sensitive Receptor GPR55

  33. 2008

    Enhancing The In Vitro Cytotoxic Activity Of Delta9-tetrahydrocannabinol In Leukemic Cells Through A Combinatorial Approach

    FavorávelEstudo LaboratorialCâncerTetraidrocanabinol (THC)
  34. 2006

    Antiproliferative activity of essential oils derived from plants belonging to the Magnoliophyta division.

    FavorávelEstudo LaboratorialCâncer
  35. 2006

    Cannabidiol-induced Apoptosis In Human Leukemia Cells: A Novel Role Of Cannabidiol In The Regulation Of P22phox And Nox4 Expression

    FavorávelEstudo LaboratorialCâncer
  36. 2006

    Delta9-tetrahydrocannabinol-induced Apoptosis in Jurkat Leukemia T Cells Is Regulated by Translocation of Bad to Mitochondria

    FavorávelEstudo LaboratorialCâncerTetraidrocanabinol (THC)
  37. 2005

    Cannabis-induced Cytotoxicity In Leukemic Cell Lines: The Role Of The Cannabinoid Receptors And The MAPK Pathway

    FavorávelEstudo LaboratorialCâncerTetraidrocanabinol (THC)
  38. 2003

    Antileukemic activity of selected natural products in Taiwan.

    FavorávelEstudo LaboratorialCâncerCâncer — Linfoma
  39. 2003

    The peripheral cannabinoid receptor Cb2, a novel oncoprotein, induces a reversible block in neutrophilic differentiation

    FavorávelEstudo LaboratorialCâncer2-Araquidonoilglicerol (2-AG)Canabinoides Sintéticos SR-x
  40. 2002

    Specific induction of apoptosis by 1,8-cineole in two human leukemia cell lines, but not a in human stomach cancer cell line.

    FavorávelEstudo LaboratorialCâncer
  41. 1975

    Antineoplastic Activity Of Cannabinoids

    FavorávelEstudo LaboratorialCâncerCâncer — PulmãoTetraidrocanabinol (THC)Canabinol (CBN)

Continue por aqui

Perguntas frequentes

Quantos estudos sobre câncer — leucemia estão indexados no acervo?
São 41 estudos, publicados entre 1975 e 2022. O acervo inteiro tem 7.640 registros.
Que tipos de estudo predominam?
Estudo Laboratorial: 24 · Metanálise: 16 · Ensaio Clínico: 1. A classificação segue o desenho declarado na fonte.
O que significa a classificação de resultado?
É uma leitura automatizada da conclusão de cada estudo, em três direções — favorável, inconclusivo e desfavorável. Aqui são 31 favoráveis, 4 inconclusivos e 6 desfavoráveis. Serve para navegar o acervo, não para concluir nada clinicamente: a conclusão válida é a do artigo original.

Como citar esta página

ABNT

CANNABIS INDICA. Câncer — Leucemia — estudos científicos sobre cannabis. 2026. Disponível em: https://cannabisindica.com.br/condicao/cancer-leucemia/. Acesso em: 13 set. 2026.

APA

Cannabis Indica. (2026). Câncer — Leucemia — estudos científicos sobre cannabis. https://cannabisindica.com.br/condicao/cancer-leucemia/

Esta página é um índice de acesso. Ao usar um estudo como evidência, cite o artigo original — o link de cada registro leva à fonte.